Elastomeric Infusion Pumps
Market
The global elastomeric infusion pumps market is set to witness an unprecedented surge, with
projections indicating a staggering growth trajectory. According to a comprehensive report spanning
the years 2024 to 2031, the market size is anticipated to soar to US$1,900 billion by 2031, marking a
substantial increase from the US$981 million recorded in 2024.
For more information: https://www.fairfieldmarketresearch.com/report/elastomeric-infusionpumps-market
Remarkable Expansion Rate Forecasted
Experts foresee the market revenue exhibiting a remarkable rate of expansion, with an estimated
Compound Annual Growth Rate (CAGR) of 9.9% during the forecast period of 2024 to 2031. This
growth is attributed to several key factors propelling the market forward, including the rise in
chronic illnesses, the burgeoning popularity of home-based treatments, and notable technological
advancements in pump design.
Key Growth Determinants
Technological Advancements: Ongoing innovations such as the development of smart pumps
featuring remote monitoring and dosage control are major drivers of growth. These advancements
enhance patient convenience, accuracy in drug delivery, and overall treatment outcomes, fueling
market expansion.
Rising Chronic Disease Burden: The increasing prevalence of chronic diseases necessitates long-term
medication administration, driving demand for cost-effective and convenient solutions like
elastomeric infusion pumps.
Growing Home Healthcare Sector: A burgeoning preference for home-based healthcare services
fuels demand for portable and easy-to-use medical devices, positioning elastomeric infusion pumps
as a preferred choice.
Major Growth Barriers
Regulatory Compliance: Stringent regulations and approval processes can significantly hinder market
growth by increasing time-to-market and operational costs for manufacturers.
Competitive Pressure: Intense competition from alternative drug delivery systems poses a challenge
to elastomeric pumps, despite their inherent advantages.
Limited Reimbursement Coverage: Varying reimbursement policies globally can impede market
growth by affecting demand and adoption rates.
Key Trends and Opportunities
Sustainable Practices: The industry is witnessing a shift towards sustainability, with a growing
emphasis on eco-friendly products and practices.
Technological Innovation: Continued investment in research and development can provide a
competitive edge, particularly in developing smart infusion pumps and incorporating advancements
in materials science.
Expansion in Developing Markets: Emerging markets present significant growth opportunities for
market players, driven by increasing healthcare expenditure and improving infrastructure.
Regional Frontrunners
North America: Leads the market with advanced healthcare infrastructure and favorable
reimbursement policies.
Europe: Emerges as a significant market driven by a rising geriatric population and government
initiatives supporting healthcare.
Leaders in the Elastomeric Infusion Pumps Market Space
1. Baxter International, Inc.
2. Fresenius Kabi AG
3. B. Braun Melsungen AG
4. Ambu A/S
5. Leventon, S.A.U.
6. Nipro Corporation
7. Terumo Corporation
8. Avanos Medical, Inc.
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum
of services, ranging from customized reports to consulting solutions. With a strong European
footprint, Fairfield operates globally and helps businesses navigate through business cycles, with
quick responses and multi-pronged approaches. The company values an eye for insightful take on
global matters, ably backed by a team of exceptionally experienced researchers. With a strong
repository of syndicated market research reports that are continuously published & updated to
ensure the ever-changing needs of customers are met with absolute promptness.
Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
LinkedIn | Twitter